Cassava Sciences Stock (NASDAQ: SAVA) stock price, news, charts, stock research, profile.
Open | $21.010 |
Close | $19.640 |
Volume / Avg. | 1.320M / 723.593K |
Day Range | 19.470 - 21.195 |
52 Wk Range | 12.320 - 32.100 |
Market Cap | $856.266M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 29.31% |
Days to Cover | 25.29 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cassava Sciences (NASDAQ: SAVA) through any online brokerage.
Other companies in Cassava Sciences’s space includes: GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA) and WAVE Life Sciences (NASDAQ:WVE).
The latest price target for Cassava Sciences (NASDAQ: SAVA) was reported by HC Wainwright & Co. on Tuesday, March 5, 2024. The analyst firm set a price target for 124.00 expecting SAVA to rise to within 12 months (a possible 526.26% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Cassava Sciences (NASDAQ: SAVA) is $19.8 last updated April 19, 2024 at 7:12 PM EDT.
A quarterly cash dividend of $0.75 per share of Class A Common Stock. The quarterly cash dividend was payable on December 24, 2012 to stockholders of record on December 13, 2012.
Cassava Sciences’s Q1 earnings are confirmed for Friday, May 3, 2024.
There is no upcoming split for Cassava Sciences.
Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.